The proceedings contain 180 papers. The topics discussed include: combined phenotype of TYMS and TYMP gene expression as a potential predictor of colorectal cancer prognosis; aberrant DNA methylation in benign, atypical and anaplastic meningiomas - preliminary results; gene expression signature of cancer stem cells in renal cell cancer; KAP1/TRIM28 multi-domain protein maintains cancer stem cell population in breast cancer; alterations in peripheral blood mononuclear cells phospholipid content in cancers; prototype biomarker panel algorithm performance for aid in early colorectal cancer detection; the TK 210 ELISA can measure increased TK1 protein levels in sera from prostate cancer patients with different Gleason scores; identification of preoperative diagnostic markers for discrimination between benign and malignant thyroid cysts by a proteomics approach; an individual reference limit for 'early' diagnosis of metastatic breast cancer during post-operative follow-up; predictive and prognostic role of serum tumor markers in patients with metastatic colorectal cancer treated with bevacizumab; macrovipera lebetina obtusa venom and obtustatin: their applications in cancer research; identification of metastatic biomarkers for head and neck squamous cell carcinoma by liquid chromatography-tandem mass spectrometry and array-based comparative genomic hybridization; and cell-free dnav600e measurements during vemurafenib therapy of metastatic melanoma patients.
CITATION STYLE
Chechlinska, M. (2016). Erratum to: Abstract supplement The 42nd Congress of the International Society of Oncology and Biomarkers “ONOCOLOGY IN THE BIOMARKER ERA: Biology – Diagnostics – Therapy” ISOBM 2015. Tumor Biology, 37(2), 2777–2778. https://doi.org/10.1007/s13277-015-4697-z
Mendeley helps you to discover research relevant for your work.